Asia Pacific neurosurgical robotics market will grow by 20.6% annually with a total addressable market cap of $6.61 billion over 2023-2032, driven by the rising number of robot-based and computer-assisted neurosurgical procedures, the advantages of neurosurgical robots, technological innovation and growing R&D investment, and the decreasing price of neurosurgical robotics.
Highlighted with 46 tables and 45 figures, this 118-page report “Asia Pacific Neurosurgical Robotics Market 2022-2032 by Offering (Robotic Systems, Instruments and Accessories, Services), Equipment Type (Robot Machines, Navigation, Planners and Simulators, Others), Application (Spinal, Cranial), Surgery Type (Open, MIS), End User (Hospitals, ASCs, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific neurosurgical robotics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2020-2022 and provides forecast from 2023 till 2032 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

  • Market Structure
  • Growth Drivers
  • Restraints and Challenges
  • Emerging Product Trends & Market Opportunities
  • Porter’s Fiver Forces


The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Asia Pacific neurosurgical robotics market in every aspect of the classification from perspectives of Offering, Equipment Type, Application, Surgery Type, End User, and Country.

Based on Offering, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

  • Robotic Systems
  • Instruments and Accessories
  • System Services



Based on Equipment Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

  • Robot Machines
  • Navigation Systems
  • Planners and Simulators
  • Other Equipment Types



By Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

  • Spinal Surgery
  • Cranial Surgery



By Surgery Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

  • Open Surgery
  • Minimally Invasive Surgery (MIS)



By End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Other End Users



Geographically, the following national/local markets are fully investigated:

  • Japan
  • China
  • South Korea
  • Australia
  • India
  • Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)


For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2022-2032. The breakdown of national markets by Offering, Application, and End User over the forecast years are also included.

The report also covers the current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Brainlab AG
DePuy Synthes (Johnson & Johnson)
Mazor Robotics Ltd.
Medtronic Inc.
Renishaw plc
Shenzhen Institutes of Advanced Technology (SIAT)
Siemens Healthineers
Simbionix USA Corp.
SONOWAND AS
Stryker Corp. / MAKO
Synaptive Medical, Inc.
Zimmer Biomet Holdings, Inc. / Medtech
(Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)